We’re delighted to announce that Gena has been added as an ‘Innovator’ on the NHS Futures Digital Health Map, marking a significant step forward in our mission to provide transformative cancer care solutions. This recognition highlights our commitment to leveraging personalised medicine for cancer care, supporting both patients and caregivers through our innovative digital healthcare solution.
Gena: Transforming Cancer Care
At Gena, we’re driven by the goal of transforming cancer care for rare cancer patients by democratising access to personalised medicine and a patient-first approach. Our platform offers personalised cancer care tools designed to empower patients and provide much-needed support to caregivers, ensuring that no one faces the journey alone and with limited information.
NHS Futures and Healthcare Innovation
The NHS Futures Platform fosters collaboration between forward-thinking organisations and healthcare professionals to advance healthcare innovation in the UK. By joining this esteemed network, Gena strengthens its ability to contribute meaningful change in digital health for rare cancer patients.
Supporting Caregivers in Cancer Care
Caregivers and family members play a vital role in the cancer care journey, often navigating complex systems while providing emotional and physical support. Gena’s tools are designed to alleviate this burden, offering tailored resources and practical solutions to empower caregivers through the provision of simple tools to help stay ontop of the cancer journey.
Driving Change within the NHS and UK Healthcare Landscape
Being recognised as an Innovator on NHS Futures allows us to collaborate more closely with healthcare leaders and policymakers to push for improvements to the standard of care. This milestone further positions Gena as a key player in delivering impactful cancer care solutions that benefit rare cancer patients, caregivers, and the broader healthcare system.
Looking Ahead
This recognition is a testament to the progress we’ve made, but it’s only the beginning. With the support of the NHS and other partners, Gena is committed to advancing the future of cancer care, fostering a holistic approach that priorities both personalised care and caregiver support.
Discover how Gena is reshaping the future of rare cancer care. Contact us here to learn more about our innovative solutions and join us on this transformative journey.
Download our cancer glossary now.
Cancer explained simply.
Skomer founded Gena after his mother passed away from Glioblastoma, a devastating brain cancer. As her caregiver and a cancer researcher, he witnessed the severe limitations in treating rare cancers.
Thus, Gena was born. Gena’s mission is to give cancer patients access to all available personalised treatment pathways. Informing better treatment decisions. Empowering cancer patients.
Skomer previously worked in the tech sector, responsible for building scaling teams. He completed his MSc at UCL’s School of Engineering in 2022, having written his dissertation on the applications of genomics within the health sector and beyond.
